Most Popular in:
New in Regulatory (page 3 of 25)
Mar 20, 2013 | 08:46 AM CDT
Ahead of a scientific meeting in Brussels, the EFSA issues a written statement saying it’s “supporting the European Commission in defining scientific criteria for endocrine disruptors."
Mar 04, 2013 | 09:19 AM CST
PureCircle has elected to formally submit its GRAS notification to the FDA for additional safety review and hopes to launch the product as early as the second half 2013.
Feb 26, 2013 | 04:26 PM CST
Panel evaluated genotoxicity of two α,β-unsaturated thiophenes from subgroup 5.2 of FGE.19 in the flavoring group evaluation 224.
Jan 28, 2013 | 10:17 AM CST
Includes benzaldehyde, α-Methylbenzyl alcohol, p-tert-Butylcyclohexanone, Anisole, Valeraldehyde, l-.alpha.-Pinene, l-.β.-Pinene and 4-Hydroxybutanoic acid lactone.
Jan 14, 2013 | 09:18 AM CST
They include (3-amino-3-carboxypropyl) dimethylsulfonium chloride, 2-ethyl-6-methylpyrazine, trimethylamine and trans-2-methyl-2-butenal.
Jan 14, 2013 | 08:07 AM CST
The organization has also opened up its scientific committee and panel meetings to external observers to promote better understanding of how scientific risk assessment is carried out.
Jan 08, 2013 | 11:54 AM CST
Notes the ingredient poses no toxicity concern for consumers at current levels of exposure and the current Acceptable Daily Intake (ADI) is safe for the general population.
Dec 19, 2012 | 11:34 AM CST
Panel finds 4-methylpent-3-en-2-one is not genotoxic; 4-methyl-3-hepten-5-one determination will be based on another group evaluation of a structurally equivalent substance.
Dec 05, 2012 | 11:53 AM CST
The results of Health Canada's evaluation of available data support the safety and efficacy of steviol glycosides when used as described.
Dec 05, 2012 | 10:40 AM CST
In response to two senators lobbying for stronger energy drink regulation, FDA says it's examining any casual risks to health, but notes other caffeine-containing products have a long history of safe use in the U.S.